Study of ZG005 in Combination With Paclitaxel＋Platinum-based ± Bevacizumab in Patients With Advanced Cervical Carcinoma
Clinical trial NCT06241235 · UNKNOWN
Trial details
- NCT number
- NCT06241235
- Sponsor
- Suzhou Zelgen Biopharmaceuticals Co.,Ltd
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-27
- Primary completion
- 2026-05-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.